Serotec has launched the only commercially available anti-human CD19 (MCA2454) monoclonal antibody suitable for paraffin-reactive immunohistological studies.
CD19 has been used widely in flow cytometry as a specific marker of B-cell lineage for leukaemias and lymphomas, and this antibody will now make immunohistological assessment of this important lineage marker possible in routinely fixed tissues. MCA2454 is a multi-purpose antibody that also works well in immunoprecipitation, Western blotting and flow cytometry following cell surface permeabilisation.